Rajeev Gupta1, Vanya Alasdair Gant2, Bryan Williams3, Tariq Enver4. 1. Stem Cell Group, UCL Cancer Institute, University College London, London, WC1E 6BT, UK; Manual Blood Sciences, Health Services Laboratories, The Halo Building, 1 Mabledon Place, London WC1H 9AX, UK. 2. Department of Microbiology, UCLH NHS Hospitals NHS Foundation Trust, 250 Euston Road, London NW1 2PG, UK. Electronic address: vanyagant@nhs.net. 3. Department of Medicine, UCLH NHS Hospitals Foundation Trust, 250 Euston Road, London NW1 2 PG, UK. 4. Stem Cell Group, UCL Cancer Institute, University College London, London, WC1E 6BT, UK.
Abstract
BACKGROUND: The reasons why some patients with COVID-19 develop pneumonia and others do not are unclear. To better understand this, we used multiparameter flow cytometry to profile circulating leukocytes from non-immunocompromised adult patients with PCR-proven COVID-19 and specifically compared those with mild symptoms with those who had developed pneumonia. METHODS: Using clinically validated antibody panels we studied leukocytes from 29 patients with PCR-proven COVID-19. Ten were hypoxic requiring ventilatory support, eleven were febrile but otherwise well, and eight were convalescing having previously required ventilatory support. Additionally, we analysed patients who did not have COVID-19 but received ventilatory support for other reasons. We examined routine Full Blood Count (FBC) specimens that were surplus to routine diagnostic requirements; normal ranges were established in a historic group of healthy volunteers. FINDINGS: We observed striking and unexpected differences in cells of the innate immune system. Levels of CD11b and CD18, which together comprise Complement Receptor 3 (CR3), were increased in granulocytes and monocytes from hypoxic COVID-19 patients, but not in those with COVID-19 who remained well, or in those without COVID-19 but ventilated for other reasons. Granulocyte and monocyte numbers were unchanged, however Natural Killer (NK) cell numbers were two-fold higher than normal in COVID-19 patients who remained well. INTERPRETATION: CR3 is central to leukocyte activation and subsequent cytokine release in response to infection. It is also a fibrinogen receptor, and its over-expression in granulocytes and monocytes of patients with respiratory failure tables it as a candidate effector of both the thrombotic and inflammatory features of COVID-19 pneumonia, and both a biomarker of impending respiratory failure and potential therapeutic target. NK cells are innate immune cells that retain immunological memory. Rapid expansion of memory NK cells targeting common antigens shared with other Coronaviruses may explain why most patients with COVID-19 do not develop respiratory complications. Understanding the innate immune response to SARS-CoV-may uncover why most infected individuals experience mild symptoms, and inform a preventive approach to COVID-19 pneumonia in the future. Crown
BACKGROUND: The reasons why some patients with COVID-19 develop pneumonia and others do not are unclear. To better understand this, we used multiparameter flow cytometry to profile circulating leukocytes from non-immunocompromised adult patients with PCR-proven COVID-19 and specifically compared those with mild symptoms with those who had developed pneumonia. METHODS: Using clinically validated antibody panels we studied leukocytes from 29 patients with PCR-proven COVID-19. Ten were hypoxic requiring ventilatory support, eleven were febrile but otherwise well, and eight were convalescing having previously required ventilatory support. Additionally, we analysed patients who did not have COVID-19 but received ventilatory support for other reasons. We examined routine Full Blood Count (FBC) specimens that were surplus to routine diagnostic requirements; normal ranges were established in a historic group of healthy volunteers. FINDINGS: We observed striking and unexpected differences in cells of the innate immune system. Levels of CD11b and CD18, which together comprise Complement Receptor 3 (CR3), were increased in granulocytes and monocytes from hypoxic COVID-19patients, but not in those with COVID-19 who remained well, or in those without COVID-19 but ventilated for other reasons. Granulocyte and monocyte numbers were unchanged, however Natural Killer (NK) cell numbers were two-fold higher than normal in COVID-19patients who remained well. INTERPRETATION: CR3 is central to leukocyte activation and subsequent cytokine release in response to infection. It is also a fibrinogen receptor, and its over-expression in granulocytes and monocytes of patients with respiratory failure tables it as a candidate effector of both the thrombotic and inflammatory features of COVID-19 pneumonia, and both a biomarker of impending respiratory failure and potential therapeutic target. NK cells are innate immune cells that retain immunological memory. Rapid expansion of memory NK cells targeting common antigens shared with other Coronaviruses may explain why most patients with COVID-19 do not develop respiratory complications. Understanding the innate immune response to SARS-CoV-may uncover why most infected individuals experience mild symptoms, and inform a preventive approach to COVID-19 pneumonia in the future. Crown
Authors: A García-Salido; M Á García-Teresa; I Leoz-Gordillo; A Martínez de Azagra-Garde; M Cabrero-Hernández; M Ramirez-Orellana Journal: Med Intensiva Date: 2020-09-30 Impact factor: 2.491
Authors: Caroline Wei Shan Hoong; Muhammad Nakib Monjur E Amin; Teck Choon Tan; Jer En Lee Journal: Int J Infect Dis Date: 2021-01-18 Impact factor: 3.623
Authors: Gergely Tibor Kozma; Tamás Mészáros; Tamás Bakos; Mark Hennies; Dániel Bencze; Barbara Uzonyi; Balázs Győrffy; Edward Cedrone; Marina A Dobrovolskaia; Mihály Józsi; János Szebeni Journal: Front Immunol Date: 2021-04-28 Impact factor: 7.561
Authors: A García-Salido; M Á García-Teresa; I Leoz-Gordillo; A Martínez de Azagra-Garde; M Cabrero-Hernández; M Ramirez-Orellana Journal: Med Intensiva (Engl Ed) Date: 2022-01
Authors: Ioannis V Kostopoulos; Nikolaos Orologas-Stavrou; Pantelis Rousakis; Chrysanthi Panteli; Ioannis Ntanasis-Stathopoulos; Ioanna Charitaki; Eleni Korompoki; Maria Gavriatopoulou; Efstathios Kastritis; Ioannis P Trougakos; Meletios-Athanasios Dimopoulos; Ourania E Tsitsilonis; Evangelos Terpos Journal: Microorganisms Date: 2021-03-06